Mycobacteriophage Derived Lipoarabinomannan Binding Protein for Recognizing Non-Tuberculosis Mycobacteria.
Xin YueQinchen LiaoHongmei HeHongtao LiJianping XieZhifeng FuPublished in: Analytical chemistry (2023)
Non-tuberculosis mycobacteria (NTM) is one family of pathogens usually leading to nosocomial infections. Exploration of high-performance biological recognition agent plays a pivotal role for the development of point-of-care testing device and kit for detecting NTM. Mycobacterium smegmatis ( M. smegmatis ) is a NTM which has been frequently applied as an alternative model for highly pathogenic mycobacteria. Herein, a recombinant tail protein derived from mycobacteriophage SWU1 infecting M. smegmatis was expressed with Escherichia coli system and noted as GP89. It shows a fist-like structure according to the results of homology modeling and ab initio modeling. It is confirmed as a lipoarabinomannan (LAM) binding protein, which can recognize studied NTM genus since abundant LAM constructed with d-mannan and d-arabinan is distributed over the mycobacterial surface. Meanwhile an enhanced green fluorescent protein (eGFP)-fused GP89 protein was acquired with a fusion expression technique. Then GP89 and eGFP-fused GP89 were applied to establish a sensitive and rapid method for fluorescent detection of M. smegmatis with a broad linear range of 1.0 × 10 2 to 1.0 × 10 6 CFU mL -1 and a low detection limit of 69 CFU mL -1 . Rapid and reliable testing of antimicrobial susceptibility was achieved by the GP89-based fluorescent method. The present work provides a promising recognition agent for studied NTM and opens an avenue for clinical diagnosis of NTM-induced infections.
Keyphrases
- binding protein
- mycobacterium tuberculosis
- loop mediated isothermal amplification
- label free
- escherichia coli
- quantum dots
- living cells
- protein protein
- amino acid
- poor prognosis
- klebsiella pneumoniae
- hiv aids
- diabetic rats
- wastewater treatment
- emergency department
- staphylococcus aureus
- hepatitis c virus
- pseudomonas aeruginosa
- hiv infected
- adverse drug
- multidrug resistant
- antimicrobial resistance
- cystic fibrosis